Hervé Hoppenot
About Hervé Hoppenot
Hervé Hoppenot is the CEO of Incyte, having significantly expanded its operations and portfolio since joining in 2014, including a 600% increase in revenue and expansion into new therapeutic areas and global markets.
Hervé Hoppenot Chief Executive Officer
Hervé Hoppenot is the Chief Executive Officer of Incyte. Since joining the company in 2014 as President and CEO, he has played a pivotal role in the company's growth and strategic direction. In 2015, he was also appointed Chairman of the Board of Directors. Under his leadership, Hervé has overseen significant expansions and achievements, contributing to Incyte's prominent position in the biopharmaceutical industry.
Hervé Hoppenot Incyte Career
Hervé Hoppenot joined Incyte in 2014 in the dual role of President and Chief Executive Officer. A year later, in 2015, he was appointed Chairman of the Board of Directors. During his tenure, he has focused on expanding Incyte's research and development pipeline, tripling the number of clinical candidates in the company's portfolio. He has also diversified the company’s focus to include inflammation and autoimmunity, areas beyond oncology. This strategic expansion has significantly bolstered the company's growth and presence in the biopharmaceutical sector.
Hervé Hoppenot Achievements at Incyte
Hervé Hoppenot has achieved substantial milestones since joining Incyte. He has tripled the number of clinical candidates in Incyte’s portfolio and increased the company’s revenue by nearly 600%. Under his leadership, five new sources of potential revenue have been added. Furthermore, he has driven the geographic expansion of the company's operations to include key regions such as North America, Europe, and Asia.
Hervé Hoppenot Previous Roles
Before his tenure at Incyte, Hervé Hoppenot served as the President of Novartis Oncology. He began his career at Novartis in 2003 as Chief Commercial Officer. Earlier in his career, he started with Rhone Poulenc, which later became known as Aventis, in 1983. His extensive experience in the pharmaceutical industry has equipped him with the knowledge and expertise to lead Incyte successfully.
Hervé Hoppenot Education
Hervé Hoppenot holds a diploma from ESSEC Business School. This educational background has provided him with a strong foundation in business and management principles, contributing to his effective leadership and strategic vision at Incyte.